Dolby Laboratories (NYSE:DLB) EVP Sells $607,843.57 in Stock

Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman sold 9,109 shares of the company’s stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $66.73, for a total value of $607,843.57. Following the completion of the transaction, the executive vice president directly owned 73,054 shares in the company, valued at approximately $4,874,893.42. This represents a 11.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Mark Andrew Sherman also recently made the following trade(s):

• On Wednesday, December 17th, Mark Andrew Sherman sold 2,491 shares of Dolby Laboratories stock. The stock was sold at an average price of $67.26, for a total value of $167,544.66.
• On Monday, December 1st, Mark Andrew Sherman sold 4,500 shares of Dolby Laboratories stock. The shares were sold at an average price of $67.56, for a total transaction of $304,020.00.

Dolby Laboratories Stock Performance

DLB stock opened at $66.26 on Friday. The company’s 50-day simple moving average is $66.78 and its 200 day simple moving average is $71.16. Dolby Laboratories has a 52 week low of $64.02 and a 52 week high of $89.66. The company has a market capitalization of $6.33 billion, a PE ratio of 25.19 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business’s revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, analysts forecast that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is currently 54.75%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on DLB. Rosenblatt Securities decreased their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, November 19th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Robert W. Baird began coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price for the company. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $92.00.

Institutional Investors Weigh In On Dolby Laboratories

A number of hedge funds have recently made changes to their positions in the stock. Cetera Investment Advisers grew its holdings in shares of Dolby Laboratories by 6.1% during the 1st quarter. Cetera Investment Advisers now owns 4,883 shares of the electronics maker’s stock valued at $392,000 after purchasing an additional 282 shares during the last quarter. Nuveen LLC acquired a new stake in Dolby Laboratories in the first quarter valued at approximately $16,890,000. Russell Investments Group Ltd. boosted its position in Dolby Laboratories by 53.7% in the first quarter. Russell Investments Group Ltd. now owns 62,918 shares of the electronics maker’s stock valued at $5,051,000 after buying an additional 21,994 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Dolby Laboratories during the first quarter worth $29,000. Finally, Ethic Inc. acquired a new position in shares of Dolby Laboratories during the first quarter worth $536,000. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.